Company ZIVO Bioscience, Inc. Other OTC

ZIVO

US98978N1019

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Special Foods & Wellbeing Products

Inactive Instrument

Zivo Bioscience, Inc. is a research and development company. The Company operates in both the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its product candidates are at different stages of development for different applications. It is developing a product candidate targeting poultry gut health. It is developing products for Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Algal biomass for human consumption, and Biomass for supporting skin health/anti-aging. It is focused on licensing and selling natural bioactive ingredients derived from their proprietary algae cultures to animal, human and dietary supplement, and medical food manufacturers.

USD in Million	2022	Weight	2023	Weight	Delta
Natural Bioactive Ingredients 100.0 %	0	nan %	0	100.0 %	-

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	0	nan %	0	100.0 %	-

Managers	Title	Age	Since
John Payne CEO	Chief Executive Officer	76	19/13/19
Keith Marchiando DFI	Director of Finance/CFO	61	01/21/01
Laura Belicka CTO	Chief Tech/Sci/R&D Officer	-	01/21/01
Harlan L. Miller CTO	Chief Tech/Sci/R&D Officer	-	-
Amy Elizabeth Steffek CTO	Chief Tech/Sci/R&D Officer	-	01/13/01
William P. Pfund CTO	Chief Tech/Sci/R&D Officer	-	01/18/01

Members of the board	Title	Age	Since
Nola E. Masterson BRD	Director/Board Member	77	17/14/17
Christopher Maggiore BRD	Director/Board Member	58	28/13/28
John Payne CEO	Chief Executive Officer	76	19/13/19
Alison Cornell BRD	Director/Board Member	62	08/21/08

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	2,802,988	1,660,259 ( 59.23 %)	0	59.23 %

Name	Equities	%	Valuation
Christopher Maggiore 12.13 %	336,816	12.13 %	2 M $
Hep Investments LLC 8.739 %	242,736	8.739 %	2 M $
Mark Strome 7.152 %	198,644	7.152 %	1 M $
Alison Cornell 2.472 %	68,666	2.472 %	474 139 $
Strome Mezzanine Fund LP 2.070 %	57,506	2.070 %	397 079 $
Column Capital Advisors LLC 0.0720 %	2,000	0.0720 %	13 810 $
John Payne 0.0564 %	1,567	0.0564 %	10 820 $
Andrew Dahl 0.0499 %	1,387	0.0499 %	9 577 $
Nola E. Masterson 0.0316 %	879	0.0316 %	6 069 $
Keith Marchiando 0.000000 %	0	0.000000 %	- $

Name	Equities	%	Valuation
Ayrton Capital LLC -	48,850	-	10 649 $

Zivo Bioscience, Inc.

21 East Long Lake Road Suite 100

48304, Bloomfield Hills

+(248) 452 9866

http://www.zivobioscience.com

Consumer Non-Cyclicals

Food & Beverages

Food & Tobacco

Food Processing

Special Foods & Wellbeing Products

	1st Jan change	Capi.
ZHEJIANG NHU COMPANY LTD.	+17.10%	8.43B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+14.30%	6.82B
THE SIMPLY GOOD FOODS COMPANY	-4.02%	3.77B
BYHEALTH CO., LTD	-7.34%	3.74B
XIAMEN KINGDOMWAY GROUP COMPANY	+1.78%	1.44B
HERBALIFE LTD.	-28.37%	1.06B
SIRIO PHARMA CO., LTD.	+18.84%	1.04B
USANA HEALTH SCIENCES, INC.	-11.29%	890M
JAMIESON WELLNESS INC.	-18.03%	812M

Special Foods & Wellbeing Products